Management of Prostatitis
Immediate Classification and Diagnostic Approach
The management of prostatitis depends entirely on accurate classification into acute bacterial prostatitis, chronic bacterial prostatitis, or chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), as each requires fundamentally different treatment strategies. 1, 2
Key Diagnostic Steps
For suspected acute bacterial prostatitis:
- Perform a gentle digital rectal examination only—avoid vigorous prostatic massage or manipulation, as this risks inducing bacteremia and sepsis 1, 3
- Obtain midstream urine culture before starting antibiotics 1, 3
- Collect blood cultures, especially if the patient is febrile 1
- Order complete blood count to assess for leukocytosis 1
- Consider transrectal ultrasound if prostatic abscess is suspected (inability to void, severe systemic toxicity, or failure to improve within 48-72 hours) 1, 4
For suspected chronic bacterial prostatitis:
- Use the Meares-Stamey 4-glass test (or simplified 2-specimen variant) to confirm bacterial localization—a 10-fold higher bacterial count in expressed prostatic secretions compared to midstream urine confirms the diagnosis 1, 3
- Test for atypical pathogens including Chlamydia trachomatis and Mycoplasma species, particularly in men under 35 years 1, 3
For suspected CP/CPPS:
- This is a diagnosis of exclusion after ruling out bacterial infection, cancer, urinary obstruction, and urinary retention 2
- Symptoms include pelvic pain for ≥3 months with urinary symptoms but negative cultures 2
Treatment of Acute Bacterial Prostatitis
Hospitalization vs Outpatient Decision
Hospitalize with IV antibiotics if:
- Unable to tolerate oral medications 1
- Signs of systemic toxicity or risk of urosepsis (occurs in 7.3% of cases) 1
- Suspected prostatic abscess 1
Outpatient oral therapy is appropriate for:
- Mild-to-moderate cases without fever who can tolerate oral medications 1
First-Line Antibiotic Selection
For outpatient mild-to-moderate cases:
- Ciprofloxacin 500-750 mg orally twice daily for 2-4 weeks if local fluoroquinolone resistance is <10% 1, 3, 2
- Do not use fluoroquinolones if the patient received them in the last 6 months or if local resistance exceeds 10% 1, 3
For hospitalized severe cases:
- Ceftriaxone 1-2 g IV daily plus doxycycline 100 mg orally every 12 hours for broad coverage 3
- Alternative: Piperacillin-tazobactam 4.5 g IV every 6-8 hours 4, 2
- Ciprofloxacin 400 mg IV twice daily can be used parenterally, transitioning to oral once clinically improved 1, 2
For men <35 years old:
- Add doxycycline 100 mg orally every 12 hours for 7 days to cover Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species 1
- Alternative: Azithromycin 1 g orally as a single dose for Mycoplasma coverage 1
Antibiotics to Avoid
- Do not use amoxicillin or ampicillin empirically—worldwide resistance rates are 75% (range 45-100%) for E. coli 1, 3
- Do not use trimethoprim-sulfamethoxazole empirically unless the organism is known to be susceptible due to high resistance rates 1
Treatment Duration and Follow-Up
- Assess clinical response after 48-72 hours of treatment 1
- Complete a total of 2-4 weeks of antibiotic therapy 5, 1, 6, 2
- Do not stop antibiotics prematurely, as this can lead to chronic bacterial prostatitis 1
Special Consideration: Prostatic Abscess
If prostatic abscess is confirmed:
- Percutaneous drainage under transrectal ultrasound guidance is mandatory—antibiotics alone are insufficient 4
- Use transrectal needle aspiration or small-bore pigtail catheter placement 4
- Start piperacillin-tazobactam 4.5 g IV every 6-8 hours or a carbapenem (ertapenem 1 g daily, meropenem 1 g every 8 hours, or imipenem-cilastatin 1 g every 6-8 hours) for multidrug-resistant organisms 4
- Culture the abscess fluid to guide targeted therapy 4
Treatment of Chronic Bacterial Prostatitis
First-Line Antibiotic Therapy
Fluoroquinolones are first-line if local resistance is <10%:
- Levofloxacin or ciprofloxacin for a minimum of 4 weeks 2
- 4-12 weeks may be required to prevent relapse 1, 6
Treatment Duration
- The 2024 JAMA Network Open guideline acknowledges insufficient evidence for clear duration recommendations, with historical durations ranging from 6 weeks or longer for chronic bacterial prostatitis 5
- However, the European Urology guidelines recommend 4-12 weeks to prevent relapse 1
- If symptoms improve after 2-4 weeks, continue treatment for at least another 2-4 weeks to achieve clinical cure and pathogen eradication 6
- Do not continue antibiotics for 6-8 weeks without reassessing effectiveness 6
Special Considerations
- Test for atypical pathogens (Chlamydia, Mycoplasma) and treat accordingly 1, 3
- Treat sexual partners if sexually transmitted infections are identified 3
- Avoid fluoroquinolones if the patient has used them in the last 6 months 3
Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
CP/CPPS is not caused by culturable bacteria and requires symptom-focused management, not prolonged antibiotics. 1, 2
First-Line Therapy
α-Blockers are first-line for urinary symptoms:
- Tamsulosin, alfuzosin, doxazosin, or terazosin are equally effective 3, 2
- These reduce NIH-CPSI score by 4.8 to 10.8 points compared to placebo 3, 2
- Common adverse effects include orthostatic hypotension, dizziness, tiredness, ejaculatory problems, and nasal congestion 3
- Tamsulosin has lower risk of orthostatic hypotension but higher risk of ejaculatory dysfunction 3
Second-Line Therapy
If α-blockers are insufficient:
- Anti-inflammatory drugs (e.g., ibuprofen) reduce NIH-CPSI score by 1.7 to 2.5 points 2
- Pregabalin reduces NIH-CPSI score by 2.4 points 2
- Pollen extract (cernilton) reduces NIH-CPSI score by 2.49 points 2
Role of Antibiotics in CP/CPPS
- A 4- to 6-week trial of a fluoroquinolone provides relief in 50% of men and is more efficacious if prescribed soon after symptoms begin 7
- However, prolonged antibiotics are not recommended if cultures are negative 1, 7
Third-Line and Refractory Options
- Pelvic floor training/biofeedback may be more effective but requires randomized controlled trials for confirmation 7
- Do not use 5α-reductase inhibitors (finasteride, dutasteride) for CP/CPPS—they are only effective for benign prostatic hyperplasia with demonstrable prostatic enlargement 3
- For treatment-refractory patients, consider transurethral microwave therapy 7
Common Pitfalls to Avoid
- Never perform vigorous prostatic massage in acute prostatitis—this can cause bacteremia and sepsis 1, 3
- Never rely on antibiotics alone for prostatic abscess—drainage is mandatory for source control 4
- Never use amoxicillin/ampicillin or trimethoprim-sulfamethoxazole empirically due to high resistance rates 1, 3
- Never stop antibiotics prematurely in acute bacterial prostatitis—this leads to chronic bacterial prostatitis 1
- Never use fluoroquinolones if local resistance exceeds 10% or if the patient used them in the last 6 months 1, 3
- Never treat CP/CPPS with prolonged antibiotics if cultures are negative—focus on symptom management with α-blockers and anti-inflammatories 1, 7, 2